Invion Limited Stock Return On Equity

7C8 Stock  EUR 0.17  0.00  0.00%   
Invion Limited fundamentals help investors to digest information that contributes to Invion's financial success or failures. It also enables traders to predict the movement of Invion Stock. The fundamental analysis module provides a way to measure Invion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Invion stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Invion Limited Company Return On Equity Analysis

Invion's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Invion Return On Equity

    
  -81.76  
Most of Invion's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Invion Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Invion Limited has a Return On Equity of -81.76. This is 241.09% higher than that of the Healthcare sector and notably lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Germany stocks is notably higher than that of the company.

Invion Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Invion's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Invion could also be used in its relative valuation, which is a method of valuing Invion by comparing valuation metrics of similar companies.
Invion is currently under evaluation in return on equity category among its peers.

Invion Fundamentals

About Invion Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Invion Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invion Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Invion Stock

Invion financial ratios help investors to determine whether Invion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Invion with respect to the benefits of owning Invion security.